Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 42 (66.7%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_3

A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer

NCT00147134
completedphase_4

Inflammatory Response in Laparoscopic and Open Colectomy

NCT00942461
completedphase_4

Oxidative Stress Markers in Open and Laparoscopic Colectomy for Cancer

NCT00928928

Clinical Trials (3)

Showing 3 of 3 trials
NCT00147134Phase 3

A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer

Completed
NCT00942461Phase 4

Inflammatory Response in Laparoscopic and Open Colectomy

Completed
NCT00928928Phase 4

Oxidative Stress Markers in Open and Laparoscopic Colectomy for Cancer

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3